Delivers annual sales of $7,536 million, with adjusted EBITDA of $1,754 million, and continued strong cash generation of $818 million
TEL AVIV, Israel--(BUSINESS WIRE)-- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Consolidated annual sales were $7,536 million versus a record $10,015 million in 2022. Net income was $647 million versus $2,159 million, while adjusted net income was $715 million versus $2,350 million. Annual adjusted EBITDA was $1,754 million versus $4,007 million in 2022. Diluted earnings per share for 2023 were $0.50, while adjusted diluted EPS was $0.55. Operating cash flow was $1,595 million in 2023, while free cash flow was $818 million. For 2023, the Company paid out more than $350 million in dividends.
For the fourth quarter of 2023, consolidated sales were $1,690 million versus $2,091 million. Net income was $67 million, with adjusted net income of $123 million, versus $331 million and $358 million, respectively, for fourth quarter 2022. Adjusted EBITDA in the fourth quarter was $357 million versus $698 million. Fourth quarter diluted earnings per share were $0.05, with adjusted diluted EPS of $0.10, versus $0.25 and $0.28, respectively. Operating cash flow was $415 million in the fourth quarter, while free cash flow was $160 million.
“ICL delivered adjusted EBITDA of $1.8 billion and operating cash flow of $1.6 billion, on the backdrop of a record 2022. During 2023, we expanded into additional new end-markets, with the groundbreaking of new advanced facilities and the launch of new innovative products, which will have a long-term impact on growth. We executed against our cost reduction plan and launched further efficiency measures in the fourth quarter, as we continued to respond to challenging market conditions and remained resilient in the face of war,” said Raviv Zoller, president and CEO of ICL. “For the year, ICL delivered significant value to shareholders, with $818 million of free cash flow and more than $350 million in dividend payments, as we diligently managed the areas under our control, swiftly reacting to changing external conditions. We currently see improving demand in our key end-markets and, while we expect there will be new and continued challenges in 2024, we are looking forward to achieving our goals for the year, including inorganic growth.”
The Company also announced it is making a change to guidance practices, in order to provide greater transparency for its shareholders. Going forward, the Company will be providing guidance for expected potash sales volumes and EBITDA guidance for all of its business segments other than potash, which will be referred to as specialties-driven business segments.
For 2024, the Company expects the specialties-driven segments adjusted EBITDA to be between $0.7 billion to $0.9 billion. For potash, the Company expects 2024 sales volumes to be between 4.6 million metric tons and 4.9 million metric tons. The Company’s fourth quarter 2023 Potash segment EBITDA should give a good indication of EBITDA at current prices, and ICL expects every $20 change in the average potash CIF price from current levels to result in a $100 million annual impact to EBITDA (1a).
Financial Figures and non-GAAP Financial Measures
10-12/2023
10-12/2022
1-12/2023
1-12/2022
$ millions
% of Sales
Sales
1,690
-
2,091
7,536
10,015
Gross profit
560
33
933
45
2,671
35
5,032
50
Operating income
149
9
540
26
1,141
15
3,516
Adjusted operating income (1)
211
12
562
27
1,218
16
3,509
Net income attributable to the Company's shareholders
67
4
331
647
2,159
22
Adjusted net income attributable to the Company’s shareholders (1)
123
7
358
17
715
2,350
23
Diluted earnings per share (in dollars)
0.05
0.25
0.50
1.67
Diluted adjusted earnings per share (in dollars) (2)
0.10
0.28
0.55
1.82
Adjusted EBITDA (2)
357
21
698
1,754
4,007
40
Cash flows from operating activities
415
467
1,595
2,025
Purchases of property, plant and equipment and intangible assets (3)
255
212
780
747
(1)
See “Adjustments to Reported Operating and Net income (non-GAAP)” below.
(2)
See “Consolidated Adjusted EBITDA and Diluted Adjusted Earnings Per Share for the periods of activity" below.
(3)
See “Condensed consolidated statements of cash flows (unaudited)” to the accompanying financial statements.
Industrial Products
Potash
Phosphate Solutions
Growing Solutions
Three-months ended 31 December
2023
2022
Segment operating income
39
95
122
340
74
116
(5)
32
Depreciation and amortization
46
59
49
20
24
Segment EBITDA
56
110
168
385
133
165
Segment Information
The Industrial Products segment produces bromine from a highly concentrated solution in the Dead Sea and bromine‑based compounds at its facilities in Israel, the Netherlands and China. In addition, the segment produces several grades of salts, magnesium chloride, magnesia-based products, phosphorus-based products, and functional fluids.
Results of operations
Segment Sales
299
349
1,227
1,766
Sales to external customers
294
343
1,206
1,737
Sales to internal customers
5
6
29
Segment Operating Income
220
628
57
61
277
689
Capital expenditures
91
90
Significant highlights
Results analysis for the period October – December 2023
Expenses
Q4 2022 figures
(254)
Quantity
63
(34)
Price
(115)
Exchange rates
2
8
Raw materials
Energy
Transportation
Operating and other expenses
3
Q4 2023 figures
(260)
The Potash segment produces and sells mainly potash, salts, magnesium, and electricity. Potash is produced in Israel using an evaporation process to extract it from the Dead Sea at Sodom and in Spain using conventional mining from an underground mine. The segment also produces and sells pure magnesium, magnesium alloys and chlorine. In addition, the segment sells salt products produced at its potash site in Spain. The segment operates a power plant in Sodom which supplies electricity and steam to ICL facilities in Israel, with surplus electricity sold to external customers.
474
713
2,182
3,313
Potash sales to external customers
336
568
1,693
2,710
Potash sales to internal customers
36
129
184
Other and eliminations (1)
89
109
360
419
Gross Profit
231
456
1,171
2,292
668
1,822
175
166
843
1,988
132
92
384
346
Potash price - CIF ($ per tonne)
345
594
393
682
Primarily includes salt produced in Spain, metal magnesium-based products, chlorine, and sales of excess electricity produced by ICL’s power plant at the Dead Sea in Israel.
Additional segment information
Global potash market - average prices and imports:
Average prices
VS Q4 2022
7-9/2023
VS Q3 2023
Granular potash – Brazil
CFR spot
($ per tonne)
570
(41.1)%
351
(4.3)%
Granular potash – Northwest Europe
CIF spot/contract
(€ per tonne)
388
813
(52.3)%
392
(1.0)%
Standard potash – Southeast Asia
318
675
(52.9)%
309
2.9%
Potash imports
To Brazil
million tonnes
3.4
1.5
126.7%
3.6
(5.6)%
To China
1.8
100.0%
2.9
24.1%
To India
0.8
0.5
60.0%
0.6
33.3%
Sources: CRU (Fertilizer Week Historical Price: January 2024), SIACESP (Brazil), World Shipping Agenciamentos (WSA), FAI, Brazil and Chinese customs data.
Potash – Production and Sales
Thousands of tons
Production
1,139
1,224
4,420
4,691
Total sales (including internal sales)
1,179
1,068
4,683
4,499
Closing inventory
284
547
Fourth quarter 2023
Full year 2023
(373)
11
13
(255)
(352)
The Phosphate Solutions segment operates ICL's phosphate value chain and uses phosphate rock and fertilizer-grade phosphoric acid to produce phosphate-based specialty products with higher added value, as well as to produce and sell phosphate-based fertilizers.
Phosphate specialties sales of $343 million and operating income of $38 million in the fourth quarter of 2023 were approximately 15% and 42% lower, respectively, compared to the fourth quarter of 2022. The decrease in operating income was driven mainly by lower selling prices and sales volumes, partially offset by lower costs of raw materials.
Sales of phosphate commodities amounted to $201 million, approximately 10% lower than in the fourth quarter of 2022. Operating income of $36 million decreased year-over-year by $14 million, primarily due to lower prices, partially offset by higher volumes sold and lower raw material costs, mainly sulphur.
544
627
2,483
3,106
503
574
2,274
2,851
41
53
209
329
777
Depreciation and amortization*
221
189
550
966
Phosphate specialties EBITDA
55
79
436
Phosphate commodities EBITDA
78
86
273
530
272
259
*
For Q4 2023, comprised of $17 million in phosphate specialties and $42 million in phosphate commodities. For Q4 2022, comprised of $13 million in phosphate specialties and $36 million in phosphate commodities.
Global phosphate commodities market - average prices:
$ per tonne
07-09/2023
DAP
CFR India Bulk Spot
734
(19)%
518
15%
TSP
CFR Brazil Bulk Spot
422
543
(22)%
394
7%
SSP
CPT Brazil inland 18-20% P2O5 Bulk Spot
278
270
3%
275
1%
Sulphur
Bulk FOB Adnoc monthly Bulk contract
102
138
(26)%
82
24%
Source: CRU (Fertilizer Week Historical Prices, January 2024).
(511)
(7)
1
(81)
(470)
The Growing Solutions segment aims to achieve global leadership in plant nutrition by enhancing its position in its core markets of specialty agriculture, ornamental horticulture, turf and landscaping, fertilizers and FertilizerpluS, and by targeting high-growth markets such as Brazil, India, and China. The segment also looks to leverage its unique R&D capabilities, substantial agronomic experience, global footprint, backward integration to potash, phosphate and polysulphate and its chemistry know-how, as well as its ability to integrate and generate synergies from acquired businesses. ICL continuously works to expand its broad portfolio of specialty plant nutrition, plant stimulation and plant health solutions, which consist of enhanced efficiency and controlled release fertilizers (CRF), water-soluble fertilizers (WSF), liquid fertilizers and straights (MKP/MAP/PeKacid), FertilizerpluS, soil and foliar micronutrients, secondary nutrients, biostimulants, soil conditioners, seed treatment products, and adjuvants.
478
527
2,073
2,422
475
513
2,047
2,376
14
51
378
68
70
119
448
38
101
(495)
98
(67)
31
(165)
18
(16)
111
(19)
(483)
Financing expenses, net
Net financing expenses in the fourth quarter of 2023 amounted to $33 million, compared to $41 million in the corresponding quarter last year, a decrease of $8 million. This decrease is mainly due to a decrease of $10 million in account receivables factoring expenses, partially offset by an increase of $2 million in interest expenses.
Tax expenses
In the fourth quarter of 2023, the Company’s reported tax expenses amounted to $33 million, compared to $158 million in the corresponding quarter of last year, reflecting an effective tax rate of 28% and 32%, respectively. The Company’s relatively low effective tax rate for this quarter was mainly due to the devaluation of the shekel against the US dollar.
Liquidity and Capital Resources
As of December 31, 2023, the Company’s cash, cash equivalents, short-term investments and deposits amounted to $592 million compared to $508 million as of December 31, 2022. In addition, the Company maintained about $1.2 billion of unused credit facilities as of December 31, 2023.
Outstanding net debt
As of December 31, 2023, ICL’s net financial liabilities amounted to $2,095 million, a decrease of $221 million compared to December 31, 2022.
Credit facilities
Sustainability-linked Revolving Credit Facility (RCF)
In April 2023, the Company entered into a Sustainability-Linked Revolving Credit Facility Agreement made between ICL Finance B.V. and a consortium of twelve international banks for a $1,550 million credit facility. The Sustainability-Linked RCF replaced a previous revolving credit facility that was entered into in 2015, as amended and extended in 2018, and which was due to expire in 2025.
As of December 31, 2023, the Company had utilized $376 million of the credit facility.
Securitization
The total amount of the Company's committed securitization facility framework is $300 million with an additional $100 million uncommitted. As of December 31, 2023, ICL had utilized approximately $182 million of the facility’s framework.
Ratings and financial covenants
Fitch Ratings
In June 2023, Fitch Ratings reaffirmed the Company’s long-term issuer default rating and senior unsecured rating at 'BBB-'. The outlook on the long-term issuer default rating is stable.
S&P Ratings
In July 2023, the S&P credit rating agency reaffirmed the Company’s international credit rating and senior unsecured rating of 'BBB-'. In addition, the S&P Maalot credit rating agency reaffirmed the Company’s credit rating of 'ilAA' with a stable rating outlook.
Financial covenants
As of December 31, 2023, the Company was in compliance with all of its financial covenants stipulated in its financing agreements.
Dividend Distribution
In connection with ICL’s fourth quarter 2023 results, the Board of Directors declared a dividend of 4.76 cents per share, or approximately $61 million. The dividend will be paid on March 26, 2024. The record date is March 14, 2024.
About ICL
ICL Group Ltd. is a leading global specialty minerals company, which creates impactful solutions for humanity’s sustainability challenges in the food, agriculture, and industrial markets. ICL leverages its unique bromine, potash, and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the Company’s growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The Company employs more than 12,500 people worldwide, and its 2023 revenue totaled approximately $7.5 billion. For more information, visit the Company’s website at www.icl-group.com1.
We disclose in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Our management uses adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. We calculate our adjusted operating income by adjusting our operating income to add certain items, as set forth in the reconciliation table under “Adjustments to reported operating, and net income (non-GAAP)” below. Certain of these items may recur. We calculate our adjusted net income attributable to the Company’s shareholders by adjusting our net income attributable to the Company’s shareholders to add certain items, as set forth in the reconciliation table under “Adjustments to reported operating, and net income (non-GAAP)” below, excluding the total tax impact of such adjustments. We calculate our diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Our adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and adjust items presented in the reconciliation table under “Consolidated adjusted EBITDA, and diluted adjusted Earnings Per Share for the periods of activity” below, which were adjusted for in calculating the adjusted operating income. Commencing with the year 2022, the Company’s “adjusted EBITDA” calculation is no longer adding back “minority and equity income, net“. While “minority and equity income, net” reflects the share of an equity investor in one of our owned operations, since adjusted EBITDA measures the Company’s overall performance, its operations and its ability to satisfy cash needs, before profit is allocated to the equity investor, management believes that adjusted EBITDA before deduction of such item is more reflective.
You should not view adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the Company’s shareholders determined in accordance with IFRS, and you should note that our definitions of adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of our non-IFRS financial measures as tools for comparison. However, we believe adjusted operating income, adjusted net income attributable to the Company’s shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of our ongoing operations. Our management uses these non-IFRS measures to evaluate the Company's business strategies, and management performance. We believe that these non IFRS measures provide useful information to investors because they improve the comparability of our financial results between periods and provide for greater transparency of key measures used to evaluate our performance.
1The reference to our website is intended to be an inactive textual reference and the information on, or accessible through, our website is not intended to be part of this Form 6-K.
(1a) The Company only provides guidance on a non-GAAP basis. The Company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the Company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material, and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. For 2023, Specialties businesses are represented by the Industrial Products, and Growing Solutions segments, and the specialties part of the Phosphate Solutions segment, and we present EBITDA from the phosphate specialties part of the Phosphate Solutions segment as we believe this information is useful to investors in reflecting the specialty portion of our business. Beginning with 2024, we are providing specialties-driven Adjusted EBITDA which will include Industrial Products, Growing Solutions and Phosphate Solutions, as the Phosphate Solutions business is now predominantly specialties-focused and for our Potash business we will be providing sales volumes guidance. The company believes this change provides greater transparency, as these new metrics are less impacted by fertilizer commodity prices, given the extreme volatility in recent years.
We present a discussion in the period-to-period comparisons of the primary drivers of change in the Company’s results of operations. This discussion is based in part on management’s best estimates of the impact of the main trends on our businesses. We have based the following discussion on our financial statements. You should read such discussion together with our financial statements.
Adjustments to Reported Operating and Net income (non-GAAP)
Provision for early retirement (1)
Write-off of assets and provision for site closure (2)
34
Legal proceedings, dispute and other settlement expenses (3)
Charges related to the security situation in Israel (4)
Divestment related items and transaction costs (5)
(29)
Total adjustments to operating income
62
77
Adjusted operating income
Net income attributable to the shareholders of the Company
Total tax adjustments (6)
(6)
(9)
198
Total adjusted net income - shareholders of the Company
For 2023, reflects provisions for early retirement, due to restructuring at certain sites, as part of the Company’s global efficiency plan.
For 2023, reflects mainly a write-off of assets related to restructuring at certain sites, including site closures and facility modifications, as part of the Company’s global efficiency plan.
For 2023, reflects a reversal of a legal provision. For 2022, reflects mainly the costs of a mediation settlement regarding the claims related to the Ashalim Stream incident.
(4)
For 2023, reflects charges relating to the security situation in Israel deriving from the war which commenced on October 7, 2023.
For 2022, reflects a capital gain related to the sale of an asset in Israel and the Company’s divestment of a 50%-owned joint venture, Novetide.
For 2023, reflects the tax impact of adjustments made to operating income. For 2022, reflects tax expenses in respect of prior years following a settlement with Israel’s Tax Authority regarding Israel's surplus profit levy, which outlines understandings for the calculation of the levy, including the measurement of fixed assets, as well as the tax impact of adjustments made to operating income.
Consolidated adjusted EBITDA and diluted adjusted Earnings Per Share for the periods of activity
Calculation of adjusted EBITDA was made as follows:
Net income
84
342
687
2,219
113
Taxes on income
158
287
1,185
Less: Share in earnings of equity-accounted investees
146
136
536
498
Adjustments (1)
Total adjusted EBITDA (2)
See "Adjustments to Reported Operating and Net income (non-GAAP)" above.
Commencing 2022, the Company’s adjusted EBITDA definition was updated, see the disclaimer above.
Calculation of diluted adjusted earnings per share was made as follows:
Total tax adjustments
Adjusted net income - shareholders of the Company
Weighted-average number of diluted ordinary shares outstanding (in thousands)
1,290,575
1,291,299
1,290,668
1,289,947
The diluted adjusted earnings per share is calculated by dividing the adjusted net income‑shareholders of the Company by the weighted-average number of diluted ordinary shares outstanding (in thousands).
Consolidated Results Analysis
(1,551)
Total adjustments Q4 2022*
Adjusted Q4 2022 figures
(1,529)
170
(84)
(601)
30
28
105
10
Adjusted Q4 2023 figures
(1,479)
Total adjustments Q4 2023*
(62)
(1,541)
* See "Adjustments to reported Operating and Net income (non-GAAP)" above.
The following table sets forth sales by geographical regions based on the location of the customers:
Europe
464
608
Asia
440
592
South America
364
396
19
North America
Rest of the world
104
137
Total
100
Forward-looking Statements
This announcement contains statements that constitute “forward‑looking statements”, many of which can be identified by the use of forward‑looking words such as “anticipate”, “believe”, “could”, “expect”, “should”, “plan”, “intend”, “estimate”, “strive”, “forecast”, “targets” and “potential”, among others.
Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward‑looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to :
Changes in exchange rates or prices compared to those we are currently experiencing; loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and our reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at our seaport shipping facilities or regulatory restrictions affecting our ability to export our products overseas; general market, political or economic conditions in the countries in which we operate; price increases or shortages with respect to our principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at our plants; labor disputes, slowdowns and strikes involving our employees; pension and health insurance liabilities; Pandemics may create disruptions, impacting our sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in our evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of our, or our service providers', information technology systems or breaches of our, or our service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from our cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of our businesses; changes in demand for our fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond our control; sales of our magnesium products being affected by various factors that are not within our control; our ability to secure approvals and permits from the authorities in Israel to continue our phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of our workers and processes; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; including the current state of war declared in Israel and any resulting disruptions to our supply and production chains; filing of class actions and derivative actions against the Company, its executives and Board members; The Company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under ”Item 3 - Key Information— D. Risk Factors" in the Company's Annual Report on Form 20-F for the year ended December 31, 2022, filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 28, 2023 (the “Annual Report”).
Forward looking statements speak only as at the date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.
This report for the fourth quarter of 2023 (the “Quarterly Report”) should be read in conjunction with the Annual Report and the report for the first, second and third quarter of 2023 published by the Company (the “prior quarterly report”), including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the U.S. SEC.
Appendix:
C ondensed Consolidated Statements of Financial Position as of (Unaudited)
December 31, 2023
December 31, 2022
Current assets
Cash and cash equivalents
420
417
Short-term investments and deposits
172
Trade receivables
1,376
1,583
Inventories
1,703
2,134
Prepaid expenses and other receivables
363
323
Total current assets
4,034
4,548
Non-current assets
Deferred tax assets
152
150
Property, plant and equipment
6,329
5,969
Intangible assets
873
852
Other non-current assets
239
Total non-current assets
7,593
7,202
Total assets
11,627
11,750
Current liabilities
Short-term debt
858
512
Trade payables
912
1,006
Provisions
85
81
Other payables
783
1,007
Total current liabilities
2,638
2,606
Non-current liabilities
Long-term debt and debentures
1,829
2,312
Deferred tax liabilities
489
423
Long-term employee liabilities
354
402
Long-term provisions and accruals
224
234
Other
60
Total non-current liabilities
2,952
3,431
Total liabilities
5,590
6,037
Equity
Total shareholders’ equity
5,768
5,464
Non-controlling interests
269
249
Total equity
5,713
Total liabilities and equity
Condensed Consolidated Statements of Income (Unaudited)
(In millions except per share data)
For the three-month
period ended
For the year ended
December 31,
Cost of sales
1,130
1,158
4,865
4,983
Selling, transport and marketing expenses
286
281
1,093
1,181
General and administrative expenses
71
260
291
Research and development expenses
Other expenses
44
128
Other income
(22)
(54)
Finance expenses
65
327
Finance income
(24)
(91)
(214)
Finance expenses, net
Share in earnings of equity-accounted investees
Income before taxes on income
117
500
974
3,404
Net income attributable to the non-controlling interests
Earnings per share attributable to the shareholders of the Company:
Basic earnings per share (in dollars)
0.26
1.68
Weighted-average number of ordinary shares outstanding:
Basic (in thousands)
1,289,449
1,289,100
1,289,361
1,287,304
Diluted (in thousands)
Condensed Consolidated Statements of Cash Flows (Unaudited)
For the three-month period ended
Adjustments for:
Exchange rate, interest and derivative, net
(51)
157
Change in provisions
(8)
(32)
(83)
(15)
159
844
1,742
Change in inventories
(72)
465
(527)
Change in trade receivables
47
252
(215)
Change in trade payables
66
(100)
(101)
(42)
Change in other receivables
37
(46)
Change in other payables
48
(210)
107
Net change in operating assets and liabilities
216
432
(723)
Interest paid, net
(37)
(38)
(106)
Income taxes paid, net of refund
(160)
(253)
(1,107)
Net cash provided by operating activities
Cash flows from investing activities
Proceeds (payments) from deposits, net
(10)
(88)
(36)
Purchases of property, plant and equipment and intangible assets
(212)
(780)
(747)
Proceeds from divestiture of assets and businesses, net of transaction expenses
Business combinations
(18)
Net cash used in investing activities
(265)
(207)
(863)
(754)
Cash flows from financing activities
Dividends paid to the Company's shareholders
(68)
(314)
(474)
(1,166)
Receipt of long-term debt
311
633
1,045
Repayments of long-term debt
(183)
(383)
(836)
(1,181)
Receipts (repayments) of short-term debt
64
(25)
(21)
Receipts (repayments) from transactions in derivatives
Dividend paid to the non-controlling interests
Net cash used in financing activities
(39)
(355)
(712)
(1,303)
Net change in cash and cash equivalents
(95)
Cash and cash equivalents as of the beginning of the period
307
473
Net effect of currency translation on cash and cash equivalents
(17)
Cash and cash equivalents as of the end of the period
Operating segment data
Activities
Reconciliations
Consolidated
For the three-month period ended December 31, 2023
Sales to external parties
408
Inter-segment sales
(114)
Total sales
Segment operating income (loss)
Other expenses not allocated to the segments
(33)
Income before income taxes
304
Operating segment data (cont'd)
Other Activities
For the three-month period ended December 31, 2022
656
(131)
(41)
244
Information based on geographical location
The following table presents the distribution of the operating segments sales by geographical location of the customer:
$
millions
% of
sales
Brazil
347
359
USA
295
333
China
283
Spain
80
United Kingdom
108
Israel
72
76
Germany
94
France
India
153
Austria
All other
353
501
Investor and Press Contact – Global Peggy Reilly Tharp VP, Global Investor Relations +1-314-983-7665 Peggy.ReillyTharp@icl-group.com
Investor and Press Contact - Israel Adi Bajayo ICL Spokesperson +972-3-6844459 Adi.Bajayo@icl-group.com
Multimedia Files: